These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 25721756)

  • 41. Rapid detection of DNMT3A R882 codon mutations allows early identification of poor risk patients with acute myeloid leukemia.
    Brewin JN; Horne GA; Bisling KE; Stewart HJ; Chevassut TJ
    Leuk Lymphoma; 2013 Jun; 54(6):1336-9. PubMed ID: 23035745
    [No Abstract]   [Full Text] [Related]  

  • 42. Two novel methods for rapid detection and quantification of DNMT3A R882 mutations in acute myeloid leukemia.
    Mancini M; Hasan SK; Ottone T; Lavorgna S; Ciardi C; Angelini DF; Agostini F; Venditti A; Lo-Coco F
    J Mol Diagn; 2015 Mar; 17(2):179-84. PubMed ID: 25554589
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Prognostic relevance of DNMT3A R882 mutations in AML patients undergoing non-myeloablative conditioning hematopoietic stem cell transplantation.
    Schmalbrock LK; Bonifacio L; Bill M; Jentzsch M; Schubert K; Grimm J; Cross M; Lange T; Vucinic V; Pönisch W; Behre G; Franke GN; Niederwieser D; Schwind S
    Bone Marrow Transplant; 2018 May; 53(5):640-643. PubMed ID: 29335621
    [No Abstract]   [Full Text] [Related]  

  • 44. Prognostic significance of DNMT3A mutations in patients with acute myeloid leukemia.
    Ibrahem L; Mahfouz R; Elhelw L; Abdsalam EM; Soliman R
    Blood Cells Mol Dis; 2015 Jan; 54(1):84-9. PubMed ID: 25172541
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Association between DNMT3A mutations and prognosis of adults with de novo acute myeloid leukemia: a systematic review and meta-analysis.
    Tie R; Zhang T; Fu H; Wang L; Wang Y; He Y; Wang B; Zhu N; Fu S; Lai X; Shi J; Huang H
    PLoS One; 2014; 9(6):e93353. PubMed ID: 24936645
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The R882H DNMT3A mutation associated with AML dominantly inhibits wild-type DNMT3A by blocking its ability to form active tetramers.
    Russler-Germain DA; Spencer DH; Young MA; Lamprecht TL; Miller CA; Fulton R; Meyer MR; Erdmann-Gilmore P; Townsend RR; Wilson RK; Ley TJ
    Cancer Cell; 2014 Apr; 25(4):442-54. PubMed ID: 24656771
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Functional Analysis of DNMT3A DNA Methyltransferase Mutations Reported in Patients with Acute Myeloid Leukemia.
    Khrabrova DA; Loiko AG; Tolkacheva AA; Cherepanova NA; Zvereva MI; Kirsanova OV; Gromova ES
    Biomolecules; 2019 Dec; 10(1):. PubMed ID: 31861499
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Structure-guided functional suppression of AML-associated DNMT3A hotspot mutations.
    Lu J; Guo Y; Yin J; Chen J; Wang Y; Wang GG; Song J
    Nat Commun; 2024 Apr; 15(1):3111. PubMed ID: 38600075
    [TBL] [Abstract][Full Text] [Related]  

  • 49. DNMT3A intragenic hypomethylation is associated with adverse prognosis in acute myeloid leukemia.
    Zhang YY; Yao DM; Zhu XW; Zhou JD; Ma JC; Yang J; Wen XM; Guo H; Lin J; Qian J
    Leuk Res; 2015 Oct; 39(10):1041-7. PubMed ID: 26242829
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Epimutations mimic genomic mutations of DNMT3A in acute myeloid leukemia.
    Jost E; Lin Q; Weidner CI; Wilop S; Hoffmann M; Walenda T; Schemionek M; Herrmann O; Zenke M; Brümmendorf TH; Koschmieder S; Wagner W
    Leukemia; 2014 Jun; 28(6):1227-34. PubMed ID: 24280869
    [TBL] [Abstract][Full Text] [Related]  

  • 51. DNMT3A mutations at R882 hotspot are only found in major clones of acute myeloid leukemia.
    Bisling KE; Brewin JN; McGovern AP; Horne GA; Rider T; Stewart HJ; Ramsahoye BH; Chevassut TJ
    Leuk Lymphoma; 2014 Mar; 55(3):711-4. PubMed ID: 23741974
    [No Abstract]   [Full Text] [Related]  

  • 52. DNA methylation and hydroxymethylation patterns in acute myeloid leukemia patients with mutations in DNMT3A and IDH1/2 and their combinations.
    Šestáková Š; Krejčík Z; Folta A; Cerovská E; Šálek C; Merkerová MD; Pecherková P; Ráčil Z; Mayer J; Cetkovský P; Remešová H
    Cancer Biomark; 2019; 25(1):43-51. PubMed ID: 30988238
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Persistence of DNMT3A mutations at long-term remission in adult patients with AML.
    Pløen GG; Nederby L; Guldberg P; Hansen M; Ebbesen LH; Jensen UB; Hokland P; Aggerholm A
    Br J Haematol; 2014 Nov; 167(4):478-86. PubMed ID: 25371149
    [TBL] [Abstract][Full Text] [Related]  

  • 54. DOT1L as a therapeutic target for the treatment of DNMT3A-mutant acute myeloid leukemia.
    Rau RE; Rodriguez BA; Luo M; Jeong M; Rosen A; Rogers JH; Campbell CT; Daigle SR; Deng L; Song Y; Sweet S; Chevassut T; Andreeff M; Kornblau SM; Li W; Goodell MA
    Blood; 2016 Aug; 128(7):971-81. PubMed ID: 27335278
    [TBL] [Abstract][Full Text] [Related]  

  • 55. AML-Associated Mutations in DNA Methyltransferase DNMT3A.
    Khrabrova DA; Yakubovskaya MG; Gromova ES
    Biochemistry (Mosc); 2021 Mar; 86(3):307-318. PubMed ID: 33838631
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Acute myeloid leukemia-associated DNMT3A p.Arg882His mutation in a patient with Tatton-Brown-Rahman overgrowth syndrome as a constitutional mutation.
    Kosaki R; Terashima H; Kubota M; Kosaki K
    Am J Med Genet A; 2017 Jan; 173(1):250-253. PubMed ID: 27991732
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Expression of myeloperoxidase in acute myeloid leukemia blasts mirrors the distinct DNA methylation pattern involving the downregulation of DNA methyltransferase DNMT3B.
    Itonaga H; Imanishi D; Wong YF; Sato S; Ando K; Sawayama Y; Sasaki D; Tsuruda K; Hasegawa H; Imaizumi Y; Taguchi J; Tsushima H; Yoshida S; Fukushima T; Hata T; Moriuchi Y; Yanagihara K; Miyazaki Y
    Leukemia; 2014 Jul; 28(7):1459-66. PubMed ID: 24457336
    [TBL] [Abstract][Full Text] [Related]  

  • 58. DNMT3A mutation leads to leukemic extramedullary infiltration mediated by TWIST1.
    Xu J; Zhang W; Yan XJ; Lin XQ; Li W; Mi JQ; Li JM; Zhu J; Chen Z; Chen SJ
    J Hematol Oncol; 2016 Oct; 9(1):106. PubMed ID: 27724883
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [The immunophenotypic and clinical characteristics of NPM1 mutated acute myeloid leukemia patients].
    Liu YR; Chang Y; Ruan GR; Qin YZ; Lai YY; Shi HX; Wang YZ; Li LD; Jiang B; Li JL
    Zhonghua Xue Ye Xue Za Zhi; 2013 Feb; 34(2):98-103. PubMed ID: 23611213
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Identification of Cell Type-Specific Effects of
    Bae SG; Kim HJ; Kim MY; Kim DDH; Shin SI; Ahn JS; Park J
    Mol Cells; 2023 Oct; 46(10):611-626. PubMed ID: 37853686
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.